Stephen Feider sold $7K of BBNX stock

Stephen Feider, Chief Financial Officer of Beta Bionics, Inc. (BBNX), sold 382 shares of BBNX stock worth $7K, per an SEC Form 4 filed Nov 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 5, 2026, 4 days before it was made public.

BBNX has moved +9.4% since the trade date, from $15.49 to $16.95 (Nov 9, 2026 close).